Business Segments · Interest Income
Pharmaceuticals — Interest Income
Vertex Pharmaceuticals Pharmaceuticals — Interest Income decreased by 3.0% to $121.90M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 4.9%, from $128.20M to $121.90M. Over 3 years (FY 2022 to FY 2025), Pharmaceuticals — Interest Income shows an upward trend with a 50.3% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
StatementSegment
CategoryLiquidity
SignalHigher is better
VolatilityModerate
First reportedQ1 2022
Last reportedQ4 2025
How to read this metric
Higher income reflects a larger cash balance or a more favorable interest rate environment.
Detailed definition
Income earned from cash, cash equivalents, and marketable securities held by the company. This reflects the yield on the...
Peer comparison
Standardized as 'Interest Income' in the non-operating section of the income statement.
Metric ID:
vrtx_segment_pharmaceuticals_interest_incomeHistorical Data
16 periods
| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $36.15M | $36.15M | $36.15M | $36.15M | $153.68M | $153.68M | $153.68M | $153.68M | $181.20M | $156.50M | $132.20M | $128.20M | $120.90M | $122.40M | $125.70M | $121.90M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +325.1% | +0.0% | +0.0% | +0.0% | +17.9% | -13.6% | -15.5% | -3.0% | -5.7% | +1.2% | +2.7% | -3.0% |
| YoY Change | — | — | — | — | +325.1% | +325.1% | +325.1% | +325.1% | +17.9% | +1.8% | -14.0% | -16.6% | -33.3% | -21.8% | -4.9% | -4.9% |
Range$36.15M – $181.20M
CAGR+38.3%
Avg YoY Growth+102.1%
Median YoY Growth-1.5%
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Vertex Pharmaceuticals's pharmaceuticals — interest income?
- Vertex Pharmaceuticals (VRTX) reported pharmaceuticals — interest income of $121.90M in Q4 2025.
- How has Vertex Pharmaceuticals's pharmaceuticals — interest income changed year-over-year?
- Vertex Pharmaceuticals's pharmaceuticals — interest income decreased by 4.9% year-over-year, from $128.20M to $121.90M.
- What is the long-term trend for Vertex Pharmaceuticals's pharmaceuticals — interest income?
- Over 3 years (2022 to 2025), Vertex Pharmaceuticals's pharmaceuticals — interest income has grown at a 50.3% compound annual growth rate (CAGR), from $144.60M to $490.90M.
- What does pharmaceuticals — interest income mean?
- Money earned from interest on the company's cash and investment holdings.